![](/wp-content/themes/yootheme/cache/b0/Massachusetts-b0ccc8bc.jpeg)
Local Cdiff information for Massachusetts
Massachusetts
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Massachusetts.
Local Cdiff information for Massachusetts
Massachusetts
Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Massachusetts.
![](/wp-content/themes/yootheme/cache/b0/Massachusetts-b0ccc8bc.jpeg)
Providers
Dr. Alan C. Moss, MD,
FACG, FEBG
Interim Chief, Department of Gastroenterology
Boston Medical Center
725 Albany Street, 6th Floor
Boston, 02118
(617) 638-6525
FMT Provider: Yes
Dr. Stacy A. Kahn, MD
Director, Fecal Microbiota Transplantation; Attending Physician, Division of Gastroenterology, Hepatology and Nutrition
Boston Children’s Hospital
300 Longwood Avenue
Boston, 02115
617-355-6058
FMT Provider: Yes
Dr. Razvan Arsenescu, MD, PhD
90 Libbey Industrial Parkway
Weymouth, 02189
781-682-0630
FMT Provider: Yes
Regulation
C. diff Infections
Total Reported Cases: 2115
Hospital Onset: 2115
Community Onset: Not reported
Related Deaths: Not reported
Available Reports
State Reporting Laws
Data Submission Required: Yes
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: Yes
LTC Facility Data Publicly Reported: No
Law/Regulation: MGL. c .111D, s. 6
State Contact
Eileen McHale
Patient Safety Ombudsman
Massachusetts Department of Public Health
Betsy Lehman Center for Patient Safety and Medical Error Reduction
99 Chauncy Street
Boston, 2111
(617) 753-7324
CLINICAL TRIALS
Xylitol Use for Decolonization of C. Difficile in Patients With IBD
Official Title: Xylitol Use for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease
Trial No. NCT05852587
Type: Interventional
Recruitment: Not Yet Recruiting
Sponsor: Brigham and Women’s Hospital
Contact: Emma McClure
617-732-9223
Gender: All
Age: 18 Years and older
Outcomes and Data Collection for FMT
Official Title: Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile
Trial No. NCT03562741
Type: Interventional
Recruitment: Recruiting
Sponsor: Kruna Patel, University of Massachusetts, Worcester
Contact: Anne Foley
Gender: All
Age: 16 years and older
FMT National Registry
Official Title: Fecal Microbiota Transplant National Registry
Trial No. NCT03325855
Type: Observational
Recruitment: Recruiting
Sponsor: American Gastroenterological Association
Contact: Sonya Serra, MSc
301-941-2616
Gender: All
Age: All ages
OpTION
Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
(708) 202-8387 ext 27001
Gender: All
Age: 18 Years and older
ROAR
Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
Gender: All
Age: 18 Years and older
Pre-emptive Prevention
Official Title: A Pre-emptive Prevention Bundle for Patients at High Risk for Hospital-onset Clostridioides Difficile
Trial No. NCT058389904
Type: Interventional
Recruitment: Recruiting
Sponsor: Brigham and Women’s Hospital
Contact: Meghan A Baker, MD, SCD
617-732-8881
617-732-8881
Gender: All
Age: 18 Years and older
C.Difficile Observational Study
Official Title: An Observational Study in Adults With Clostridioides Difficile Infection to Determine the Feasibility and Logistics of Biospecimen Collection, Transportation and Testing at Select US Study Sites
Trial No. NCT06277999
Type: Observational
Recruitment: Recruiting
Sponsor: AstraZeneca
Contact: AstraZeneca Clinical Study Information Center
Gender: All
Age: 18 Years and older
RESTORATiVE303
Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.